Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes.

Goedel A, Zawada DM, Zhang F, Chen Z, Moretti A, Sinnecker D.

J Vis Exp. 2018 Sep 27;(139). doi: 10.3791/58134.

PMID:
30320759
2.

Finding the right balance.

Goedel A, Sarafoff N.

Int J Cardiol. 2018 Sep 27. pii: S0167-5273(18)34978-7. doi: 10.1016/j.ijcard.2018.09.095. [Epub ahead of print] No abstract available.

PMID:
30274748
3.

Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity.

Dorn T, Kornherr J, Parrotta EI, Zawada D, Ayetey H, Santamaria G, Iop L, Mastantuono E, Sinnecker D, Goedel A, Dirschinger RJ, My I, Laue S, Bozoglu T, Baarlink C, Ziegler T, Graf E, Hinkel R, Cuda G, Kääb S, Grace AA, Grosse R, Kupatt C, Meitinger T, Smith AG, Laugwitz KL, Moretti A.

EMBO J. 2018 Jun 15;37(12). pii: e98133. doi: 10.15252/embj.201798133. Epub 2018 May 15.

4.

Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.

Goedel A, My I, Sinnecker D, Moretti A.

Curr Cardiol Rep. 2017 Mar;19(3):23. doi: 10.1007/s11886-017-0828-z. Review.

PMID:
28220464
5.

Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.

Chen Z, Xian W, Bellin M, Dorn T, Tian Q, Goedel A, Dreizehnter L, Schneider CM, Ward-van Oostwaard D, Ng JK, Hinkel R, Pane LS, Mummery CL, Lipp P, Moretti A, Laugwitz KL, Sinnecker D.

Eur Heart J. 2017 Jan 21;38(4):292-301. doi: 10.1093/eurheartj/ehw189. No abstract available.

6.

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.

Bernlochner I, Goedel A, Plischke C, Schüpke S, Haller B, Schulz C, Mayer K, Morath T, Braun S, Schunkert H, Siess W, Kastrati A, Laugwitz KL.

Eur Heart J. 2015 Dec 1;36(45):3202-10. doi: 10.1093/eurheartj/ehv326. Epub 2015 Jul 27.

PMID:
26216931
7.

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.

Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Schötterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz KL, Gawaz MP, Moretti A.

EMBO Mol Med. 2015 May;7(5):562-76. doi: 10.15252/emmm.201505047.

8.

Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets.

Orban M, Goedel A, Haas J, Sandrock-Lang K, Gärtner F, Jung CB, Zieger B, Parrotta E, Kurnik K, Sinnecker D, Wanner G, Laugwitz KL, Massberg S, Moretti A.

PLoS One. 2015 Jan 21;10(1):e0115978. doi: 10.1371/journal.pone.0115978. eCollection 2015.

9.

Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity.

Dorn T, Goedel A, Lam JT, Haas J, Tian Q, Herrmann F, Bundschu K, Dobreva G, Schiemann M, Dirschinger R, Guo Y, Kühl SJ, Sinnecker D, Lipp P, Laugwitz KL, Kühl M, Moretti A.

Stem Cells. 2015 Apr;33(4):1113-29. doi: 10.1002/stem.1923.

10.

B-lymphoblastic lymphoma: a heartening diagnosis.

Goedel A, Hoellein A, Rischpler C, Götze K.

Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):116. doi: 10.1093/ehjci/jeu177. Epub 2014 Sep 16. No abstract available.

PMID:
25227266
11.

Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.

Sinnecker D, Goedel A, Laugwitz KL, Moretti A.

Circ Res. 2013 Mar 15;112(6):961-8. doi: 10.1161/CIRCRESAHA.112.268623. Review.

PMID:
23569105
12.

Modeling long-QT syndromes with iPS cells.

Sinnecker D, Goedel A, Dorn T, Dirschinger RJ, Moretti A, Laugwitz KL.

J Cardiovasc Transl Res. 2013 Feb;6(1):31-6. doi: 10.1007/s12265-012-9416-1. Epub 2012 Oct 18. Review.

PMID:
23076501
13.

Induced pluripotent stem cells in cardiovascular research.

Sinnecker D, Dirschinger RJ, Goedel A, Moretti A, Lipp P, Laugwitz KL.

Rev Physiol Biochem Pharmacol. 2012;163:1-26. doi: 10.1007/112_2012_6. Review.

PMID:
22447279
14.

Recapitulating long-QT syndrome using induced pluripotent stem cell technology.

Dirschinger RJ, Goedel A, Moretti A, Laugwitz KL, Sinnecker D.

Pediatr Cardiol. 2012 Aug;33(6):950-8. doi: 10.1007/s00246-012-0286-8. Epub 2012 Mar 13.

PMID:
22411718
15.

Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.

Jung CB, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, Dorn T, Ruppenthal S, Pfeiffer S, Goedel A, Dirschinger RJ, Seyfarth M, Lam JT, Sinnecker D, Gudermann T, Lipp P, Laugwitz KL.

EMBO Mol Med. 2012 Mar;4(3):180-91. doi: 10.1002/emmm.201100194. Epub 2012 Jan 25.

16.

[Membranous glomerulonephritis as a paraneoplastic manifestation of melanoma].

Sultan-Bichat N, Vuiblet V, Winckel A, Journet J, Goedel AL, Khoury A, Bernard P, Grange F.

Ann Dermatol Venereol. 2011 Jan;138(1):46-9. doi: 10.1016/j.annder.2010.10.024. Epub 2010 Nov 30. French.

PMID:
21276462
17.

Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A, Laugwitz KL.

N Engl J Med. 2010 Oct 7;363(15):1397-409. doi: 10.1056/NEJMoa0908679. Epub 2010 Jul 21.

Supplemental Content

Loading ...
Support Center